Literature DB >> 26347129

[Very high frequency ultrasound: New therapeutic method in aesthetic medicine and dermatology].

I Kruglikov1.   

Abstract

Very high frequency ultrasound (VHF-US) is new therapy method with a broad application spectrum in dermatology and aesthetic medicine. In this method, ultrasound waves with frequencies over 10 MHz, which were for a long time only used in ultrasound diagnostics, are applied for therapeutic purposes. Such US waves demonstrate specific biophysical efficiencies which warrant their application for the treatment of the skin efflorescences, chronic wounds and hypertrophic scars as well as in anti-aging and skin improvement procedures in aesthetic medicine. VHF-US can be applied not only for stand-alone treatments, but also as a supportive pre- and posttreatment method in combination with laser, radiofrequency currents, injection lipolysis, etc. as well as in aesthetic plastic surgery.

Entities:  

Keywords:  Anti-aging; Chronic wounds; Skin improvement; Skin rash; Supportive treatment methods

Mesh:

Year:  2015        PMID: 26347129     DOI: 10.1007/s00105-015-3676-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  21 in total

Review 1.  Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation.

Authors:  Douglas L Miller
Journal:  Prog Biophys Mol Biol       Date:  2006-08-22       Impact factor: 3.667

2.  Osteogenic differentiation of human adipose-derived stem cells can be accelerated by controlling the frequency of continuous ultrasound.

Authors:  Kyung Shin Kang; Jung Min Hong; Jo A Kang; Jong-Won Rhie; Dong-Woo Cho
Journal:  J Ultrasound Med       Date:  2013-08       Impact factor: 2.153

Review 3.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

4.  Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.

Authors:  Sewon Kang; Soyun Cho; Jin Ho Chung; Craig Hammerberg; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Low-frequency ultrasound treatment of chronic venous ulcers.

Authors:  M Weichenthal; P Mohr; W Stegmann; E W Breitbart
Journal:  Wound Repair Regen       Date:  1997 Jan-Mar       Impact factor: 3.617

6.  Matrix metalloproteinase-9 delays wound healing in a murine wound model.

Authors:  Matthew J Reiss; Yan-Ping Han; Edwin Garcia; Mytien Goldberg; Hong Yu; Warren L Garner
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

7.  Expression of heat shock proteins after ultrasound exposure in HL-60 cells.

Authors:  Werner Sontag; Ilja L Kruglikov
Journal:  Ultrasound Med Biol       Date:  2009-03-13       Impact factor: 2.998

Review 8.  Heat shock proteins in diabetes and wound healing.

Authors:  Mustafa Atalay; Niku Oksala; Jani Lappalainen; David E Laaksonen; Chandan K Sen; Sashwati Roy
Journal:  Curr Protein Pept Sci       Date:  2009-02       Impact factor: 3.272

9.  Differential expression of heat shock protein 70 in well healing and chronic human wound tissue.

Authors:  M Oberringer; H P Baum; V Jung; C Welter; J Frank; M Kuhlmann; W Mutschler; R G Hanselmann
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575

10.  Heat shock proteins modulate keloid formation.

Authors:  Serhat Totan; Anthony Echo; Eser Yuksel
Journal:  Eplasty       Date:  2011-04-29
View more
  2 in total

Review 1.  Caveolin-1 as a pathophysiological factor and target in psoriasis.

Authors:  Ilja L Kruglikov; Philipp E Scherer
Journal:  NPJ Aging Mech Dis       Date:  2019-02-05

2.  Acoustic Waves in Axonal Membrane and Caveolins are the New Targets for Pain Treatment with High Frequency Ultrasound.

Authors:  Ilja Kruglikov
Journal:  J Pain Res       Date:  2020-11-02       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.